Companies /Healthcare

Accuray Inc

NASDAQ: ARAY Medical Devices
$2.61
▼ $0.19 (−6.91%) today
Markets open · 1:44pm ET

ARAY at a Glance

Valuation
Market cap
$8.4M
Profitability
Revenue (TTM)
$394.5M
Profit margin
-4.4%
EPS (TTM)
$-5.60
Price
52-week range
$3 – $45
Street target
$0.35
Earnings
Next report
Feb 2, 2027

Headquartered in Madison, WI Fiscal year ends June NASDAQ: ARAY accuray.com

About Accuray

Accuray Incorporated develops, manufactures, sells and services radiation therapy systems for oncology, neuro-radiosurgery and other uses.

Its platforms include the CyberKnife System, which is used widely for stereotactic body radiation therapy (SBRT) and combines precision treatment delivery with real-time motion management.

The company earns revenue in two ways:
- Product sales of treatment systems, tracked through gross orders and backlog.
- Recurring service contracts across a global installed base of systems, which make up most of revenue and carry improving margins from pricing actions.

Accuray also holds an equity-method investment in a China joint venture.

It is executing a multi-year transformation plan aimed at lowering its cost structure and improving commercial performance. It is also deleveraging through a financing transaction with TCW that includes a debt-for-convertible-preferred exchange.

Its innovation strategy includes:
- a definitive agreement with RaySearch to accelerate online adaptive radiation therapy
- a collaboration with Samsung NeuroLogica on volumetric imaging for the CyberKnife System Updated

ARAY Coverage

8:52am ET
Investing

Top Active Trader Alert Stocks (ARAY, BSDM, CYPB, JOYG)

Active traders and day traders have many stocks to choose from this Wednesday morning.  We are tracking news and moves in shares of Acuray Incorporated, Inc. (NASDAQ: ARAY), BSD Medical corporation (NASDAQ: BSDM), Cypress Bioscience…

Douglas A. McIntyre
4:00pm ET
Investing

The 52-Week Low Club (CDNS)(ARAY)(RNOW)(CRUS)(HSTX)

Cadence Design Systems (CDNS) posts bad numbers and gets downgrades. Falls to $9.90 from 52-week high of $24.90. Accuray (ARAY) The radiosurgery device maker reported disappointing fiscal second-quarter results. Trades off to…

Douglas A. McIntyre
5:35pm ET
Health and Healthcare

Accuray, Neither Recession Proof Nor Credit Proof (ARAY)

Accuray Inc. (NASDAQ: ARAY) is being punished in after-hours trading.  The company posted earnings at $0.04 EPS on revenues of $52 million.  The problem is that First Call was at $0.09 EPS…

Douglas A. McIntyre
3:09pm ET
Investing

The 52-Week Low Club

Accuray (ARAY) Radiosurgery company has quarterly loss. Down to $12.90 from 52-week high of $31.09. Home Solutions (HSOA) Problems with credit facility. Down to $2.85 from 52-week high of $8.24. Tarragon (TARR)…

Douglas A. McIntyre

Frequently Asked Questions

What does Accuray do?

Accuray Incorporated develops, manufactures, sells and services radiation therapy systems for oncology, neuro-radiosurgery and other uses.

What is the ARAY stock price target?

The Wall Street consensus 12-month price target for ARAY is $0.35.